Influence
May 18, 2020

Regenstrief president shares data exchange experience with Becker’s Hospital Review

Becker’s Hospital Review interviewed Regenstrief President and Chief Executive Officer Peter Embí, M.D., about the statewide data sharing effort to gather information on COVID-19. Dr. Embí played a major role to lead the collaborative effort among state agencies, academic institutions and the Indiana Health Information Exchange (IHIE) to create a visual dashboard displaying hospitalizations, demographics, comorbidities and other information related to the virus outbreak. The information is being used to inform Indiana leaders.

Dr. Embí stressed the importance of the state’s health information exchange in creating the dashboard. Indiana has one of the most robust exchanges in the country and has been receiving data from every hospital system during the COVID-19 pandemic. He also stated that Indiana’s experience has proven that applying informatics expertise is essential for creating COVID-19-specific data exchanges.

Becker’s Hospital Review provides hospital and health system news, best practices, and legal guidance specifically for high-level hospital leaders. The publication has gained a reputation as one of the most trustworthy sources for data and research on healthcare delivery and administration.

Read the article

Related News

Gonzalez quote graphic

National Academy of Medicine names Gonzalez a scholar in diagnostic excellence

Regenstrief researcher developing AI methodology to identify asymptomatic patients with leading cause of limb amputation INDIANAPOLIS – Andrew Gonzalez,

Dr. Jennifer Marratt headshot

NCCN Guidelines® Insights: Colorectal Cancer Screening, Version 1.2024

Published in Journal of the National Comprehensive Cancer Network. Here is a link to the article. Regenstrief Institute author:

Preparing for widespread use of biomarkers to diagnose Alzheimer’s disease

Factors for consideration include patient characteristics, test accuracy, ethical issues INDIANAPOLIS – For years many people with Alzheimer’s disease